Blog / Archives
Pathway Genomics Makes Giant Marketing Step in Personalized Medicine
Genotyping on a Fast Track Direct to Consumer Pathway Genomics is offering a "Health Kit" that reports your genetic risk for 70 diseases such as Cancer,Cardiovascular Disease,RA,and Diabetes....
Response Genetics(RGDX) Signs Agreement with Glaxo for BRAF Gene
Response Genetics(RGDX) announced a deal today for a non-exclusive license to provide GlaxoSmithKline (GSK) with certain rights to proprietary BRAF mutational analysis technology in human tumor...
Biomarkers Drive Personalized Medicine
Companion Diagnostics Enable More Targeted Therapy At the 2010 BIO Conference in Chicago with about 15,000 attendees there were ten Breakout Sessions on Biomarkers (BM) encompassing Intellectual...
Dendreon(DNDN) Receives FDA Approval for Therapeutic Cancer Vaccine
New Treatment Category for Cancer-Autologous Cellular Immunotherapy The FDA cleared the first therapeutic vaccine for cancer with Dendreon's Provenge (R)(Sipuleucel-T), an individualized treatment...
Milken Institute Global Conference-Healthcare Reform I
Missed Opportunity in Health Reform-Wellness and Prevention On Monday April 26 a panel of executives and leaders including Michael Milken, moderated by CNBC anchor Maria Bartiromo convened to...
Gilead(GILD) and Abbott(ABT) Guidance Triggers Biotech Sell-Off
Healthcare Reform Impact on Gilead HIV Product Sales Surprises Analysts Gilead Sciences (GILD) lowered its 2010 sales forecast to a range of $7.4-$7.5B from $7.6-$7.8B citing recently enacted...
Genomics Update from AACR: Biomarkers for Oncology Medicine
Yesterday we presented an overview of the use of Biomarkers(BM's) for predictive use in the treatment of Lung Cancer. Here are some additional summaries from the American Association for Cancer...
Helicos(HLCS) Update
GenomeWeb published an update (scroll down)on Helicos on Friday April 16. Full Year Revenues for fiscal 2009 were $3M and although R&D and Admin expenses were cut the Net Loss for the Year was...
Genomics Update: Biomarkers Help Select Personalized Oncology Medicine
At yesterday's AACR (American Association of Cancer Research) Meeting in Washington DC researchers presented results from the Battle Trial which is a hypothesis- driven prospective study that...
Goldman Charge Curbs Enthusiasm for Market Risk
Larger Cap Healthcare Stocks Holding Up Well The SEC charges against Goldman Sachs have taken the MO out of the market with speculative issues down considerably. As of midday trading the Dow is down...